Azenta, Inc.

AZTA US Health Care Life Sciences Tools & Services
S&P 600
$30.85
+2.22%
Delayed · cached 15 min

Fair value analysis

AZTA
Azenta, Inc.
Health CareLife Sciences Tools & Services
$30.85
Close used for this calculation
$21.50Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
31/100
Profitability11/25
Returns1/25
Balance Sheet15/25
Efficiency4/25
Growth6/25
Weak
Quality radar
31Prof.11/25Ret.1/25Eff.4/25B.Sht15/25Growth6/25

Consensus fair value

$21.50
Above FV
▼ -30.3% against the close used
Model range $12.92 – $28.78
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$12.92Fair value$21.50Bull$28.78
FairClose
52-week traded range
52W low $16.0252W high $41.01

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Azenta, Inc. closed at $30.85, 43.5% above the consensus fair value of $21.50 drawn from 6 valuation models.

Financial DNA score 31/100 — Weak. P/E of 27.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$22.03
-28.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
$28.78
-6.7%
√(22.5 × EPS × BVPS)
EPS=1.11, BVPS=33.17 · outside Graham range (P/E 27.8, P/B 0.9) — asset-light, treat as a rough floor
P/E Fair Value
$22.20
-28.0%
EPS × 20x (sector P/E)
EPS=1.11, Sector P/E=20x
Peter Lynch (PEG)
$12.92
-58.1%
EPS × Growth% (PEG = 1 is fair)
EPS=1.11, g=11.6%
Reverse DCF
$30.85
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 11.6% | Historical: 11.6%
Margin of Safety
$18.25
-40.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=24.34, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.